tiprankstipranks
Trending News
More News >
Newmed Energy Limited Partnership (IL:NWMD)
:NWMD

Newmed Energ Pu (NWMD) AI Stock Analysis

Compare
3 Followers

Top Page

IL

Newmed Energ Pu

(OTC:NWMD)

Rating:76Outperform
Price Target:
1,804.00
▲(8.94%Upside)
The overall score reflects Newmed Energ Pu's strong valuation with a low P/E ratio and high dividend yield, indicating it is attractively priced. Financial performance is robust, with a strong return on equity and efficient cash flow generation, despite a slight decline in revenue growth. Technical analysis supports a bullish sentiment, though caution is advised due to overbought indicators.

Newmed Energ Pu (NWMD) vs. iShares MSCI Israel ETF (EIS)

Newmed Energ Pu Business Overview & Revenue Model

Company DescriptionNewmed Energy Pu (NWMD) is a company engaged in the energy sector, focusing on the exploration, development, and production of natural gas and oil resources. The company operates within the energy and utilities industry, delivering essential energy products and services to a diverse range of markets and customers.
How the Company Makes MoneyNewmed Energy Pu generates revenue primarily through the extraction and sale of natural gas and oil. The company explores and develops energy resources, which are then produced and distributed to various markets, including industrial, commercial, and residential sectors. Key revenue streams include the sale of extracted natural gas and oil, as well as potential partnerships with other energy companies for joint exploration and development initiatives. Additionally, Newmed Energy may engage in long-term supply contracts with domestic and international buyers, providing a stable and predictable revenue flow.

Newmed Energ Pu Financial Statement Overview

Summary
Newmed Energ Pu demonstrates solid financial health with strong profitability and cash flow metrics, although revenue growth has slightly declined. The balance sheet reflects a balanced leverage position with good return on equity, suggesting stability and efficient use of resources. Overall, the financial outlook is positive with potential for growth if revenue trends are addressed.
Income Statement
75
Positive
The company exhibits strong profitability with a high gross profit margin of 67.75% and a solid EBIT margin of 64.63% in TTM (Trailing-Twelve-Months). However, the revenue growth rate shows a slight decline of 1.60% from the previous year. Despite this, the net profit margin remains robust at 46.50%, indicating efficient cost management.
Balance Sheet
68
Positive
Newmed Energ Pu has a moderate debt-to-equity ratio of 0.86, which suggests a balanced leverage position. The equity ratio is at 45.39%, indicating a reasonable level of equity funding. Return on Equity (ROE) is strong at 28.20%, demonstrating effective use of shareholders' funds to generate profits.
Cash Flow
80
Positive
The company's free cash flow to net income ratio is favorable at 0.96, showing efficient conversion of profits into cash. Operating cash flow to net income ratio is also strong at 1.18, reflecting good cash generation relative to net profits. Free cash flow growth is positive at 7.76%, indicating healthy cash flow expansion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.12B1.14B934.60M1.14B882.50M587.10M
Gross Profit757.60M718.10M780.70M701.70M518.11M535.48M
EBITDA875.00M874.80M782.70M872.10M633.90M454.00M
Net Income519.90M524.60M433.60M469.70M404.90M365.30M
Balance Sheet
Total Assets4.06B3.99B3.85B3.94B3.85B4.58B
Cash, Cash Equivalents and Short-Term Investments437.40M384.50M186.70M418.30M340.85M239.35M
Total Debt1.59B1.63B1.82B2.16B2.22B3.25B
Total Liabilities2.22B2.21B2.33B2.65B2.91B3.59B
Stockholders Equity1.84B1.79B1.51B1.29B938.54M997.70M
Cash Flow
Free Cash Flow499.20M463.30M423.10M405.80M423.25M163.59M
Operating Cash Flow613.40M577.50M559.50M504.70M453.64M328.68M
Investing Cash Flow-212.70M-114.20M36.10M-273.50M982.04M-241.82M
Financing Cash Flow-453.30M-441.20M-588.90M-429.10M-1.29B-187.92M

Newmed Energ Pu Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1656.00
Price Trends
50DMA
1441.84
Positive
100DMA
1364.60
Positive
200DMA
1220.65
Positive
Market Momentum
MACD
56.36
Negative
RSI
72.50
Negative
STOCH
88.54
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1656 is above the 20-day moving average (MA) of 1529.75, above the 50-day MA of 1441.84, and above the 200-day MA of 1220.65, indicating a bullish trend. The MACD of 56.36 indicates Negative momentum. The RSI at 72.50 is Negative, neither overbought nor oversold. The STOCH value of 88.54 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$5.37B10.1231.13%5.46%
77
Outperform
$12.71B11.2111.86%7.98%5.86%-3.40%
77
Outperform
3.43B19.74
10.80%9.89%-5.73%
76
Outperform
19.66B10.2430.42%4.38%6.84%18.87%
64
Neutral
6.11B16.002.07%7.38%33.60%18.24%
56
Neutral
10.48B238.56
-18.73%86.94%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:NWMD
Newmed Energ Pu
1,675.00
839.40
100.46%
IL:NVPT
Navitas Ptro Pu
10,360.00
5,724.00
123.47%
IL:TMRP
Tamar Pet
4,331.00
2,612.97
152.09%
IL:RATI
Ratio Pu
485.00
239.82
97.81%
IL:DLEKG
Delek Group
69,500.00
32,981.88
90.32%

Newmed Energ Pu Corporate Events

Newmed Energ Pu Withdraws Class Action in Settlement with Chevron
Feb 18, 2025

Newmed Energ Pu announced the withdrawal of a class action lawsuit against Chevron Mediterranean Limited, as part of a broader settlement negotiation. The agreement, reached with mutual consent, was filed with authorities and includes scheduled hearings to ensure compliance and implementation of the terms. The companies will continue collaborative efforts to resolve outstanding issues and maintain shareholder updates following key hearings.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 23, 2025